润都股份(002923.SZ)：氢氯噻嗪获化学原料药上市申请批准

Core Viewpoint - The company, Rundu Co., Ltd. (002923.SZ), has received approval from the National Medical Products Administration for the listing application of hydrochlorothiazide, indicating a significant advancement in its product portfolio [1] Company Summary - Rundu Co., Ltd. has recently announced the receipt of a marketing approval notification for hydrochlorothiazide, a chemical raw material drug [1] - Hydrochlorothiazide is indicated for the treatment of edema-related diseases, hypertension, central or renal diabetes insipidus, and kidney stones [1]